NCT06104098View on ClinicalTrials.gov

A User Study With Vernivia® for Bacterial Vaginosis.

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

July 20, 2021

Study Completion Date

July 22, 2021

Conditions
Bacterial Vaginoses
Interventions
DEVICE

D005 vaginal mousse

D005 Vaginal Mousse is class IIa medical device for treatment of Bacterial Vaginosis.

Trial Locations (7)

11435

2Heal Medical, Stockholm

21141

Mama Mia Barnmorskemottagning, Malmo

23439

Hälsomedicinskt Center, Lomma

25467

Mama Mia Väla, Väla

58758

Mednika AB, Linköping

61131

Kvinnohälsan Stadsfjärden, Nyköping

85230

Ondrasek Läkarmottagning, Sundsvall

Sponsors
All Listed Sponsors
collaborator

Key2Compliance

INDUSTRY

collaborator

Replior AB

UNKNOWN

lead

PepTonic Medical AB

INDUSTRY